You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

MPN

Showing 1 - 25 of 263
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Accelerated Phase MPN, Blast Phase MPN Trial (zelavespib)

Withdrawn
  • Accelerated Phase MPN
  • Blast Phase MPN
  • (no location specified)
Nov 4, 2022

Myeloproliferative Tumor, Polycythemia Vera, Essential Thrombocythemia Trial in Hong Kong

Recruiting
  • Myeloproliferative Neoplasm
  • +7 more
    • Hong Kong, Hong Kong
      Department of Medicine, Queen Mary Hospital
    May 21, 2023

    MDS/MPN Trial in Nanjing (Azacitidine (AZA) with Ruxolitinib)

    Recruiting
    • MDS/MPN
    • Azacitidine (AZA) with Ruxolitinib
    • Nanjing, Jiangsu, China
      The First Affiliated Hospital of Nanjing Medical University
    Apr 17, 2023

    Myelofibrosis (PMF), Post Essential Thrombocythemia Myelofibrosis (ET-MF), Post Polycythemia Vera Related Myelofibrosis (PV-MF)

    Not yet recruiting
    • Myelofibrosis (PMF)
    • +2 more
    • New York, New York
      Ruttenberg Treatment Center
    Apr 18, 2023

    MDS, Myeloproliferative Tumor, Anemia Trial in Tampa (Luspatercept)

    Recruiting
    • Myelodysplastic Syndromes
    • +2 more
    • Tampa, Florida
      Moffitt Cancer Center
    Feb 16, 2023

    MDS/MPN Trial in Nashville (ASTX727, Itacitinib)

    Recruiting
    • MDS/MPN
    • Nashville, Tennessee
      Vanderbilt-Ingram Cancer Center
    Jun 20, 2022

    Myeloproliferative Tumor, MPN, Essential Thrombocythemia Trial in Orange (N-Acetylcysteine)

    Active, not recruiting
    • Myeloproliferative Neoplasm
    • +4 more
    • Orange, California
      Chao Family Comprehensive Cancer Center, University of Californi
    Jan 6, 2023

    Quality of Life, Cancer Trial (Online Yoga)

    Completed
    • Quality of Life
    • Cancer
    • Online Yoga
    • (no location specified)
    Feb 23, 2022

    Myelodysplastic/Myeloproliferative Tumor With Ring Sideroblasts and Thrombocytosis, Myelodysplastic/Myeloproliferative Tumor,

    Recruiting
    • Myelodysplastic/Myeloproliferative Neoplasm With Ring Sideroblasts and Thrombocytosis
    • Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Jan 6, 2023

    Myelofibrosis, Polycythemia Vera Trial in United States (TGR-1202, ruxolitinib)

    Active, not recruiting
    • Myelofibrosis
    • Polycythemia Vera
    • Phoenix, Arizona
    • +4 more
    Jun 20, 2022

    MDS, Myeloproliferative Tumor Trial in United States (Azacitidine Subcutaneous Injection or Intravenous Infusion, Pevonedistat

    Active, not recruiting
    • Myelodysplastic Syndromes
    • Myeloproliferative Neoplasm
    • Azacitidine Subcutaneous Injection or Intravenous Infusion
    • +2 more
    • Miami, Florida
    • +4 more
    Jun 20, 2022

    Chronic Myelomonocytic Leukemia, Myelodysplastic Syndrome, Myelodysplastic Syndrome With Excess Blasts Trial (Biospecimen

    Not yet recruiting
    • Chronic Myelomonocytic Leukemia
    • +3 more
    • Biospecimen Collection
    • +3 more
    • (no location specified)
    Oct 27, 2022

    SARS-CoV-2 Acute Respiratory Disease Trial (Povidone Iodine 5% Soln,Top,Kit)

    Not yet recruiting
    • SARS-CoV-2 Acute Respiratory Disease
    • Povidone Iodine 5% Soln,Top,Kit
    • (no location specified)
    Feb 24, 2023

    Myelofibrosis, Essential Thrombocythemia, MPN Trial in New York (Peptide-based vaccine, Poly ICLC)

    Not yet recruiting
    • Myelofibrosis
    • +2 more
    • Peptide-based vaccine
    • Poly ICLC
    • New York, New York
      Icahn School of Medicine at Mount Sinai
    Jun 7, 2022

    Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Myeloproliferative Tumor (MDS/MPN) Trial in Durham (ADCT-301)

    Recruiting
    • Acute Myeloid Leukemia (AML)
    • +2 more
    • Durham, North Carolina
      Duke University Health System
    Jan 10, 2022

    MDS, MDS/MPN Crossover Syndromes Trial in Cleveland (5-azacytidine, Decitabine)

    Recruiting
    • Myelodysplastic Syndromes
    • MDS/MPN Crossover Syndromes
    • Cleveland, Ohio
      Cleveland Medical Center, University Hospitals Seidman Cancer Ce
    Aug 10, 2022

    Primary Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis, ET-MF Trial in New York (Canakinumab)

    Recruiting
    • Primary Myelofibrosis
    • +4 more
    • New York, New York
      Ruttenberg Treatment Center
    Jul 18, 2022

    Myeloproliferative Tumor, Chronic Phase Chronic Myelogenous Leukemia, Chronic Myeloid Leukemia Trial in San Francisco (Online

    Recruiting
    • Myeloproliferative Neoplasm
    • +2 more
    • Online Mindfulness Meditation
    • Internet-Based Webinars
    • San Francisco, California
      University of California San Francisco
    Aug 9, 2022

    Myeloproliferative Tumor (MPN), Myelofibrosis,MF Trial in Chengdu (flonoltinib 25mg, flonoltinib 50mg, flonoltinib 100mg)

    Recruiting
    • Myeloproliferative Neoplasm (MPN)
    • Myelofibrosis，MF
    • flonoltinib 25mg
    • +5 more
    • Chengdu, Sichuan, China
      West China Hospital Sichuan University
    Mar 9, 2022

    MDS, Myeloproliferative Tumors, Myelofibrosis Trial (Jaktinib, azacitidine)

    Not yet recruiting
    • Myelodysplastic Syndromes
    • +2 more
    • (no location specified)
    Nov 29, 2021

    Myeloproliferative Tumors Trial in Taoyuan

    Enrolling by invitation
    • Myeloproliferative Neoplasms
      • Taoyuan, State, Taiwan
        Chang Gung Memorial Hospital-Linkou
      Aug 4, 2021

      Anemia, MDS Trial in Germany (Canakinumab Injection)

      Recruiting
      • Anemia
      • Myelodysplastic Syndromes
      • Canakinumab Injection
      • Berlin, Germany
      • +5 more
      Nov 8, 2022

      Myeloproliferative Tumor (MPN), Myelofibrosis,MF Trial (flonoltinib 25mg, flonoltinib 50mg, flonoltinib 100mg)

      Not yet recruiting
      • Myeloproliferative Neoplasm (MPN)
      • Myelofibrosis，MF
      • flonoltinib 25mg
      • +5 more
      • (no location specified)
      Nov 2, 2021

      Graft Vs Host Disease, Peripheral Blood Stem Cell Transplantation, AML Trial in Germany (Cyclophosphamide, ATG)

      Recruiting
      • Graft Vs Host Disease
      • +5 more
      • Augsburg, Germany
      • +15 more
      Aug 2, 2022

      Myeloproliferative Tumor Trial in New York (Vactosertib)

      Recruiting
      • Myeloproliferative Neoplasm
      • New York, New York
        Weill Medical College of Cornell University
      Dec 20, 2021